MPW Relative Valuation
MPW's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MPW is overvalued; if below, it's undervalued.
Historical Valuation
Medical Properties Trust Inc (MPW) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.80 is considered Undervalued compared with the five-year average of 12.88. The fair price of Medical Properties Trust Inc (MPW) is between 4.10 to 9.42 according to relative valuation methord. Compared to the current price of 4.08 USD , Medical Properties Trust Inc is Undervalued By 0.55%.
Relative Value
Fair Zone
4.10-9.42
Current Price：4.08
0.55%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.57
P/B
Median3y
0.58
Median5y
0.94
6.29
FCF Yield
Median3y
13.28
Median5y
10.31
Competitors Valuation Multiple
The average P/S ratio for MPW's competitors is 1.87, providing a benchmark for relative valuation. Medical Properties Trust Inc Corp (MPW) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -17.51%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Medical Properties Trust Inc (MPW) currently overvalued or undervalued?
What is Medical Properties Trust Inc (MPW) fair value?
How does MPW's valuation metrics compare to the industry average?
What is the current P/B ratio for Medical Properties Trust Inc (MPW) as of Jul 20 2025?
What is the current FCF Yield for Medical Properties Trust Inc (MPW) as of Jul 20 2025?
What is the current Forward P/E ratio for Medical Properties Trust Inc (MPW) as of Jul 20 2025?